Table 5.
Incident rates and median time for T2DM diagnosis at different follow-up times, according to hypertension and CVD diagnosis
| |
|
Statin use |
|||
|---|---|---|---|---|---|
| |
|
Yes |
No |
||
| Follow up time (years) PS [5-95%] (N = 1,448,993) | Hazard ratio (95% CI)* | Incident T2DM per 1000 person-years (95% CI) | Nº T2DM /Median time (days) | Incident T2DM per 1000 person-years (95% CI) | Nº T2DM /Median time (days) |
|
Total sample | |||||
|
0-1 yr |
1.52 (1.47-1.57) |
19.97 (19.52-20.42) |
7,634/139 |
11.53 (11.33-11.74) |
12,189/210 |
|
1-3 yr |
1.22 (1.19-1.25) |
20.11 (19.78-20.44) |
13,786/727 |
13.35 (13.34-13.37) |
21,418/644 |
|
3-5 yr |
1.73 (1.68-1.80) |
24.56 (24.12-25.00) |
11,858/1,440 |
11.61 (11.38-11.84) |
9,773/1,394 |
|
5-10 yr |
2.25 (2.17-2.34) |
30.03 (29.55-30.53) |
14,523/2,450 |
10.85 (10.59-11.12) |
6,534/2,312 |
|
10-15 yr |
3.05 (2.71-3.43) |
34.93 (33.53-36.39) |
2,292/4,174 |
10.20 (9.38-11.10) |
543/4,166 |
|
15-20 yr |
3.63 (2.44-5.38) |
42.24 (36.90-48.36) |
210/5,877 |
12.24 (9.10-16.51) |
43/5,773 |
|
20-25 yr |
n.e. |
13.10 (1.84-93.00) |
1/ - |
0 |
0/ - |
|
No hypertension | |||||
|
0-1 yr |
2.05 (1.96-2.15) |
19.53 (18.97-20.11) |
4,486/134 |
8.65 (8.44-8.85) |
6,893/215 |
|
1-3 yr |
1.50 (1.45-1.55) |
18.64 (18.23-19.06) |
7,694/727 |
10.60 (10.42-10.77) |
13,114/653 |
|
3-5 yr |
2.00 (1.92-2.09) |
22.15 (21.61-22.69) |
6,463/1,439 |
9.56 (9.33-9.80) |
6,550/1,400 |
|
5-10 yr |
2.50 (2.39-2.61) |
27.65 (27.06-28.24) |
8,502/2,482 |
9.32 (9.06-9.59) |
4,750/2,335 |
|
10-15 yr |
3.14 (2.75-3.58) |
32.86 (31.26-34.55) |
1,541/4,180 |
9.31 (8.48-10.21) |
446/4,186 |
|
15-20 yr |
3.84 (2.52-5.86) |
41.61 (35.64-48.59) |
160/5,877 |
11.55 (8.41-15.88) |
38/5,780 |
|
20-25 yr |
n.e. |
0 |
0/ - |
0 |
0/ - |
|
Hypertension | |||||
|
0-1 yr |
0.96 (0.91-1.01) |
20.62 (19.91-21.35) |
3,148/145 |
20.40 (19.86-20.96) |
5,296/204 |
|
1-3 yr |
0.84 (0.81-0.88) |
22.33 (21.77-22.89) |
6,092/726 |
24.20 (23.68-24.72) |
8,304/625 |
|
3-5 yr |
1.22 (1.15-1.29) |
28.24 (27.50-29.00) |
5,395/1,442 |
20.51 (19.82-21.23) |
3,223/1,380 |
|
5-10 yr |
1.56 (1.46-1.67) |
34.22 (33.37-35.10) |
6,021/2,405 |
19.25 (18.38-20.17) |
1,784/2,264 |
|
10-15 yr |
2.19 (1.68-2.84) |
40.09 (37.32-43.06) |
751/4,156 |
18.33 (15.02-22.37) |
97/4,073 |
|
15-20 yr |
2.32 (0.77-7.01) |
44.38 (33.64-58.56) |
50/5,876 |
22.38 (9.31-53.77) |
5/ - |
|
20-25 yr |
n.e. |
0 |
0/ - |
0 |
0/ - |
|
No CVD | |||||
|
0-1 yr |
1.74 (1.67-1.80) |
20.72 (20.22-21.24) |
6,260/136 |
10.74 (10.54-10.95) |
10,474/213 |
|
1-3 yr |
1.31 (1.28-1.35) |
20.37 (19.99-20.75) |
11,037/725 |
12.93 (12.75-13.11) |
19,254/647 |
|
3-5 yr |
1.85 (1.78-1.92) |
24.94 (24.44-25.45) |
9,325/1,438 |
11.18 (10.95-11.42) |
9,022/1,393 |
|
5-10 yr |
2.34 (2.24-2.43) |
30.44 (29.86-31.02) |
10,512/2,416 |
10.56 (10.30-10.83) |
6,134/2,317 |
|
10-15 yr |
2.96 (2.61-3.35) |
33.58 (31.85-35.97) |
1,379/4,151 |
10.08 (9.26-10.99) |
523/4,166 |
|
15-20 yr |
3.76 (2.49-5.67) |
41.78 (35.54-49.11) |
147/5,985 |
11.81 (8.70-16.04) |
41/5,773 |
|
20-25 yr |
n.e. |
0 |
0/ - |
0 |
0/ - |
|
CVD | |||||
|
0-1 yr |
0.75 (0.69-0.82) |
17.11 (16.23-18.04) |
1,374/147 |
21.05 (20.08-22.07) |
1,715/196 |
|
1-3 yr |
0.75 (0.70-0.80) |
19.12 (18.42-19.85) |
2,749/733 |
23.77 (22.79-24.79) |
2,164/613 |
|
3-5 yr |
0.97 (0.88-1.06) |
23.24 (22.35-24.17) |
2,533/1,445 |
21.30 (19.83-22.88) |
751/1,408 |
|
5-10 yr |
1.34 (1.19-1.50) |
29.05 (28.16-29.96) |
4,011/2,540 |
18.73 (16.98-20.66) |
400/2,223 |
|
10-15 yr |
2.26 (1.42-3.57) |
37.19 (34.85-39.68) |
913/4,224 |
14.70 (9.49-22.79) |
20/4,204 |
|
15-20 yr |
1.45 (0.31-6.74) |
43.36 (33.87-55.08) |
63/5,762 |
48.47 (12.12-193.81) |
2/ - |
| 20-25 yr | n.e. | 0 | 0/ - | 0 | 0/ - |
PS – propensity score; *Final model: adjusted for age and propensity score; n.e. – no estimation.